Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Nutraceutical

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1637064

Cover Image

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1637064

Probiotic Strains Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032

PUBLISHED:
PAGES: 152 Pages
DELIVERY TIME: 2-5 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4995
Unprintable PDF & Excel (Multi User License upto 5 users)
USD 8495
Printable PDF & Excel (Enterprise License above 5 users)
USD 10600

Add to Cart

Description

Table of Contents

The global probiotic strains market is experiencing significant growth, driven by rising consumer awareness of gut health and its connection to overall well-being. With a projected compound annual growth rate (CAGR) of 8.10%, the market is set to expand from $6.54 billion in 2025 to $11.28 billion by 2032. This growth underscores the increasing demand for probiotic-rich products across various sectors.

Market Insights

Probiotic strains refer to beneficial microorganisms, including bacteria and yeast, that support digestive health and enhance overall wellness. The market focuses on leveraging these strains to address specific health concerns, boost immunity, and provide a natural approach to preventive healthcare. Innovations in probiotic research and product diversification continue to fuel market growth, with applications spanning dietary supplements, functional foods, and beverages.

The probiotic strains market is positioned for dynamic growth, driven by consumer interest in health-conscious lifestyles, scientific advancements, and innovative applications. Companies that focus on sustainability, regulatory compliance, and personalized solutions will be well-placed to capture emerging opportunities and lead the market's evolution. With its promising trajectory, the probiotic strains market is set to play a crucial role in shaping the future of health and wellness.

Key Market Drivers

  • 1. Rising Consumer Awareness and Health Consciousness: Increasing understanding of the gut microbiota's role in overall health has driven demand for probiotics. Consumers are actively seeking products to support digestion, boost immunity, and address gut-related issues.
  • 2. Scientific Advancements in Probiotics: Ongoing research has enabled the customization of strains to target specific health concerns, offering tailored solutions and boosting consumer confidence in probiotic products.

Business Opportunities

  • 1. Diversification of Applications: Probiotic strains are increasingly being incorporated into functional foods, beverages, and even pet nutrition. These new applications cater to the rising trend of health-conscious lifestyles.
  • 2. Personalized Probiotics: Advancements in microbiome research allow for tailored probiotic formulations that align with individual health profiles, offering targeted benefits and tapping into the personalized healthcare trend.

Market Restraints

  • 1. Regulatory Challenges: Varying regulatory frameworks across regions pose significant hurdles for market entry and compliance, emphasizing the need for harmonized guidelines.
  • 2. Sustainability Concerns: Resource-intensive production processes highlight the need for eco-friendly solutions to balance demand with environmental sustainability.

Regional Analysis

  • 1. Europe: The region dominates the market due to a robust R&D infrastructure, stringent quality standards, and a strong emphasis on preventive healthcare. The demand for probiotic-enriched functional foods and supplements is particularly high.
  • 2. South Asia & Oceania: This region represents the fastest-growing market, driven by increasing consumer awareness and a rising population adopting probiotic-rich diets.

Recent Developments

  • 1. KeVita Expands Probiotic Beverages Line: In January 2023, KeVita launched mango-flavored Sparkling Probiotic Lemonade, available in major US retail chains. This expansion enhances market penetration by catering to diverse consumer tastes.
  • 2. Nestle Enters Chinese Market: In September 2022, Nestle Garden of Life introduced its first probiotic product in China's infant food category, addressing the growing demand for early-life health solutions.
  • 3. BioGaia Launches Respiratory Health Probiotic: In July 2022, BioGaia Pharax debuted in the UK, reflecting the industry's focus on expanding probiotic applications beyond digestive health.

Key Players Prominent companies driving innovation in the probiotic strains market include:

  • Hansen Holding A/S
  • Probi
  • Aumgene Bioscience
  • Virchow Biotech Private Limited
  • Merck KGaA
  • Koninklijke DSM N.V.
  • BioGaia
  • Morinaga Milk Industry Co., Ltd.

These companies are leveraging competitive intelligence, strategic collaborations, and product diversification to strengthen their market positions.

Market Segmentation

1. By Type:

    Lactobacillus acidophilus (dominant due to its proven efficacy in gut health) Lactobacillus rhamnosus GG Bifidobacterium bifidum (fastest-growing category) Others

2. By Form:

    Dry (dominant due to stability and versatility) Liquid (fast-growing, driven by consumer preference for innovative formulations)

3. By End-use Application:

    Dietary Supplements (largest segment) Functional Foods (fastest-growing segment) Pharmaceuticals Animal Feed Food and Beverages (e.g., yogurt drinks, fermented milk, and bakery items)

4. By Region:

    North America Europe East Asia South Asia & Oceania Latin America Middle East & Africa
Show more

Table of Contents

1. Executive Summary

  • 1.1. Global Probiotic Strains Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2025
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Probiotic Strains Market Outlook, 2019 - 2032

  • 3.1. Global Probiotic Strains Market Outlook, by Type, Value (US$ Bn), 2019 - 2032
    • 3.1.1. Key Highlights
      • 3.1.1.1. Lactobacillus acidophilus
      • 3.1.1.2. Lactobacillus rhamnoses GG
      • 3.1.1.3. Bifidobacterium bifidum
      • 3.1.1.4. Others
  • 3.2. Global Probiotic Strains Market Outlook, by Form, Value (US$ Bn), 2019 - 2032
    • 3.2.1. Key Highlights
      • 3.2.1.1. Dry
      • 3.2.1.2. Liquid
  • 3.3. Global Probiotic Strains Market Outlook, by End Use Application, Value (US$ Bn), 2019 - 2032
    • 3.3.1. Key Highlights
      • 3.3.1.1. Food and Beverages
      • 3.3.1.2. Yogurt Drink and Fermented Milk
      • 3.3.1.3. Fruit Juice
      • 3.3.1.4. Bakery
      • 3.3.1.5. Meat Products
      • 3.3.1.6. Pharmaceuticals
      • 3.3.1.7. Functional Food
      • 3.3.1.8. Animal Feed
      • 3.3.1.9. Dietary Supplement
  • 3.4. Global Probiotic Strains Market Outlook, by Region, Value (US$ Bn), 2019 - 2032
    • 3.4.1. Key Highlights
      • 3.4.1.1. North America
      • 3.4.1.2. Europe
      • 3.4.1.3. Asia Pacific
      • 3.4.1.4. Latin America
      • 3.4.1.5. Middle East & Africa

4. North America Probiotic Strains Market Outlook, 2019 - 2032

  • 4.1. North America Probiotic Strains Market Outlook, by Type, Value (US$ Bn), 2019 - 2032
    • 4.1.1. Key Highlights
      • 4.1.1.1. Lactobacillus acidophilus
      • 4.1.1.2. Lactobacillus rhamnoses GG
      • 4.1.1.3. Bifidobacterium bifidum
      • 4.1.1.4. Others
  • 4.2. North America Probiotic Strains Market Outlook, by Form, Value (US$ Bn), 2019 - 2032
    • 4.2.1. Key Highlights
      • 4.2.1.1. Dry
      • 4.2.1.2. Liquid
  • 4.3. North America Probiotic Strains Market Outlook, by End Use Application, Value (US$ Bn), 2019 - 2032
    • 4.3.1. Key Highlights
      • 4.3.1.1. Food and Beverages
      • 4.3.1.2. Yogurt Drink and Fermented Milk
      • 4.3.1.3. Fruit Juice
      • 4.3.1.4. Bakery
      • 4.3.1.5. Meat Products
      • 4.3.1.6. Pharmaceuticals
      • 4.3.1.7. Functional Food
      • 4.3.1.8. Animal Feed
      • 4.3.1.9. Dietary Supplement
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis
  • 4.4. North America Probiotic Strains Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 4.4.1. Key Highlights
      • 4.4.1.1. Probiotic Strains Market by Type, Value (US$ Bn), 2019 - 2032
      • 4.4.1.2. Probiotic Strains Market by Form, Value (US$ Bn), 2019 - 2032
      • 4.4.1.3. Probiotic Strains Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 4.4.1.4. Canada Probiotic Strains Market by Type, Value (US$ Bn), 2019 - 2032
      • 4.4.1.5. Canada Probiotic Strains Market by Form, Value (US$ Bn), 2019 - 2032
      • 4.4.1.6. Canada Probiotic Strains Market by End Use Application, Value (US$ Bn), 2019 - 2032
    • 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Probiotic Strains Market Outlook, 2019 - 2032

  • 5.1. Europe Probiotic Strains Market Outlook, by Type, Value (US$ Bn), 2019 - 2032
    • 5.1.1. Key Highlights
      • 5.1.1.1. Lactobacillus acidophilus
      • 5.1.1.2. Lactobacillus rhamnoses GG
      • 5.1.1.3. Bifidobacterium bifidum
      • 5.1.1.4. Others
  • 5.2. Europe Probiotic Strains Market Outlook, by Form, Value (US$ Bn), 2019 - 2032
    • 5.2.1. Key Highlights
      • 5.2.1.1. Dry
      • 5.2.1.2. Liquid
  • 5.3. Europe Probiotic Strains Market Outlook, by End Use Application, Value (US$ Bn), 2019 - 2032
    • 5.3.1. Key Highlights
      • 5.3.1.1. Food and Beverages
      • 5.3.1.2. Yogurt Drink and Fermented Milk
      • 5.3.1.3. Fruit Juice
      • 5.3.1.4. Bakery
      • 5.3.1.5. Meat Products
      • 5.3.1.6. Pharmaceuticals
      • 5.3.1.7. Functional Food
      • 5.3.1.8. Animal Feed
      • 5.3.1.9. Dietary Supplement
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis
  • 5.4. Europe Probiotic Strains Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 5.4.1. Key Highlights
      • 5.4.1.1. Germany Probiotic Strains Market by Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.2. Germany Probiotic Strains Market by Form, Value (US$ Bn), 2019 - 2032
      • 5.4.1.3. Germany Probiotic Strains Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 5.4.1.4. U.K. Probiotic Strains Market by Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.5. U.K. Probiotic Strains Market by Form, Value (US$ Bn), 2019 - 2032
      • 5.4.1.6. U.K. Probiotic Strains Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 5.4.1.7. France Probiotic Strains Market by Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.8. France Probiotic Strains Market by Form, Value (US$ Bn), 2019 - 2032
      • 5.4.1.9. France Probiotic Strains Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 5.4.1.10. Italy Probiotic Strains Market by Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.11. Italy Probiotic Strains Market by Form, Value (US$ Bn), 2019 - 2032
      • 5.4.1.12. Italy Probiotic Strains Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 5.4.1.13. Turkey Probiotic Strains Market by Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.14. Turkey Probiotic Strains Market by Form, Value (US$ Bn), 2019 - 2032
      • 5.4.1.15. Turkey Probiotic Strains Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 5.4.1.16. Russia Probiotic Strains Market by Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.17. Russia Probiotic Strains Market by Form, Value (US$ Bn), 2019 - 2032
      • 5.4.1.18. Russia Probiotic Strains Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 5.4.1.19. Rest of Europe Probiotic Strains Market by Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.20. Rest of Europe Probiotic Strains Market by Form, Value (US$ Bn), 2019 - 2032
      • 5.4.1.21. Rest of Europe Probiotic Strains Market by End Use Application, Value (US$ Bn), 2019 - 2032
    • 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Probiotic Strains Market Outlook, 2019 - 2032

  • 6.1. Asia Pacific Probiotic Strains Market Outlook, by Type, Value (US$ Bn), 2019 - 2032
    • 6.1.1. Key Highlights
      • 6.1.1.1. Lactobacillus acidophilus
      • 6.1.1.2. Lactobacillus rhamnoses GG
      • 6.1.1.3. Bifidobacterium bifidum
      • 6.1.1.4. Others
  • 6.2. Asia Pacific Probiotic Strains Market Outlook, by Form, Value (US$ Bn), 2019 - 2032
    • 6.2.1. Key Highlights
      • 6.2.1.1. Dry
      • 6.2.1.2. Liquid
  • 6.3. Asia Pacific Probiotic Strains Market Outlook, by End Use Application, Value (US$ Bn), 2019 - 2032
    • 6.3.1. Key Highlights
      • 6.3.1.1. Food and Beverages
      • 6.3.1.2. Yogurt Drink and Fermented Milk
      • 6.3.1.3. Fruit Juice
      • 6.3.1.4. Bakery
      • 6.3.1.5. Meat Products
      • 6.3.1.6. Pharmaceuticals
      • 6.3.1.7. Functional Food
      • 6.3.1.8. Animal Feed
      • 6.3.1.9. Dietary Supplement
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis
  • 6.4. Asia Pacific Probiotic Strains Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 6.4.1. Key Highlights
      • 6.4.1.1. China Probiotic Strains Market by Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.2. China Probiotic Strains Market by Form, Value (US$ Bn), 2019 - 2032
      • 6.4.1.3. China Probiotic Strains Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 6.4.1.4. Japan Probiotic Strains Market by Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.5. Japan Probiotic Strains Market by Form, Value (US$ Bn), 2019 - 2032
      • 6.4.1.6. Japan Probiotic Strains Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 6.4.1.7. South Korea Probiotic Strains Market by Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.8. South Korea Probiotic Strains Market by Form, Value (US$ Bn), 2019 - 2032
      • 6.4.1.9. South Korea Probiotic Strains Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 6.4.1.10. India Probiotic Strains Market by Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.11. India Probiotic Strains Market by Form, Value (US$ Bn), 2019 - 2032
      • 6.4.1.12. India Probiotic Strains Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 6.4.1.13. Southeast Asia Probiotic Strains Market by Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.14. Southeast Asia Probiotic Strains Market by Form, Value (US$ Bn), 2019 - 2032
      • 6.4.1.15. Southeast Asia Probiotic Strains Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 6.4.1.16. Rest of Asia Pacific Probiotic Strains Market by Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.17. Rest of Asia Pacific Probiotic Strains Market by Form, Value (US$ Bn), 2019 - 2032
      • 6.4.1.18. Rest of Asia Pacific Probiotic Strains Market by End Use Application, Value (US$ Bn), 2019 - 2032
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Probiotic Strains Market Outlook, 2019 - 2032

  • 7.1. Latin America Probiotic Strains Market Outlook, by Type, Value (US$ Bn), 2019 - 2032
    • 7.1.1. Key Highlights
      • 7.1.1.1. Lactobacillus acidophilus
      • 7.1.1.2. Lactobacillus rhamnoses GG
      • 7.1.1.3. Bifidobacterium bifidum
      • 7.1.1.4. Others
  • 7.2. Latin America Probiotic Strains Market Outlook, by Form, Value (US$ Bn), 2019 - 2032
    • 7.2.1. Key Highlights
      • 7.2.1.1. Dry
      • 7.2.1.2. Liquid
  • 7.3. Latin America Probiotic Strains Market Outlook, by End Use Application, Value (US$ Bn), 2019 - 2032
    • 7.3.1. Key Highlights
      • 7.3.1.1. Food and Beverages
      • 7.3.1.2. Yogurt Drink and Fermented Milk
      • 7.3.1.3. Fruit Juice
      • 7.3.1.4. Bakery
      • 7.3.1.5. Meat Products
      • 7.3.1.6. Pharmaceuticals
      • 7.3.1.7. Functional Food
      • 7.3.1.8. Animal Feed
      • 7.3.1.9. Dietary Supplement
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis
  • 7.4. Latin America Probiotic Strains Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 7.4.1. Key Highlights
      • 7.4.1.1. Brazil Probiotic Strains Market by Type, Value (US$ Bn), 2019 - 2032
      • 7.4.1.2. Brazil Probiotic Strains Market by Form, Value (US$ Bn), 2019 - 2032
      • 7.4.1.3. Brazil Probiotic Strains Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 7.4.1.4. Mexico Probiotic Strains Market by Type, Value (US$ Bn), 2019 - 2032
      • 7.4.1.5. Mexico Probiotic Strains Market by Form, Value (US$ Bn), 2019 - 2032
      • 7.4.1.6. Mexico Probiotic Strains Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 7.4.1.7. Argentina Probiotic Strains Market by Type, Value (US$ Bn), 2019 - 2032
      • 7.4.1.8. Argentina Probiotic Strains Market by Form, Value (US$ Bn), 2019 - 2032
      • 7.4.1.9. Argentina Probiotic Strains Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 7.4.1.10. Rest of Latin America Probiotic Strains Market by Type, Value (US$ Bn), 2019 - 2032
      • 7.4.1.11. Rest of Latin America Probiotic Strains Market by Form, Value (US$ Bn), 2019 - 2032
      • 7.4.1.12. Rest of Latin America Probiotic Strains Market by End Use Application, Value (US$ Bn), 2019 - 2032
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Probiotic Strains Market Outlook, 2019 - 2032

  • 8.1. Middle East & Africa Probiotic Strains Market Outlook, by Type, Value (US$ Bn), 2019 - 2032
    • 8.1.1. Key Highlights
      • 8.1.1.1. Lactobacillus acidophilus
      • 8.1.1.2. Lactobacillus rhamnoses GG
      • 8.1.1.3. Bifidobacterium bifidum
      • 8.1.1.4. Others
  • 8.2. Middle East & Africa Probiotic Strains Market Outlook, by Form, Value (US$ Bn), 2019 - 2032
    • 8.2.1. Key Highlights
      • 8.2.1.1. Dry
      • 8.2.1.2. Liquid
  • 8.3. Middle East & Africa Probiotic Strains Market Outlook, by End Use Application, Value (US$ Bn), 2019 - 2032
    • 8.3.1. Key Highlights
      • 8.3.1.1. Food and Beverages
      • 8.3.1.2. Yogurt Drink and Fermented Milk
      • 8.3.1.3. Fruit Juice
      • 8.3.1.4. Bakery
      • 8.3.1.5. Meat Products
      • 8.3.1.6. Pharmaceuticals
      • 8.3.1.7. Functional Food
      • 8.3.1.8. Animal Feed
      • 8.3.1.9. Dietary Supplement
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis
  • 8.4. Middle East & Africa Probiotic Strains Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 8.4.1. Key Highlights
      • 8.4.1.1. GCC Probiotic Strains Market by Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.2. GCC Probiotic Strains Market by Form, Value (US$ Bn), 2019 - 2032
      • 8.4.1.3. GCC Probiotic Strains Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 8.4.1.4. South Africa Probiotic Strains Market by Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.5. South Africa Probiotic Strains Market by Form, Value (US$ Bn), 2019 - 2032
      • 8.4.1.6. South Africa Probiotic Strains Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 8.4.1.7. Egypt Probiotic Strains Market by Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.8. Egypt Probiotic Strains Market by Form, Value (US$ Bn), 2019 - 2032
      • 8.4.1.9. Egypt Probiotic Strains Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 8.4.1.10. Nigeria Probiotic Strains Market by Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.11. Nigeria Probiotic Strains Market by Form, Value (US$ Bn), 2019 - 2032
      • 8.4.1.12. Nigeria Probiotic Strains Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 8.4.1.13. Rest of Middle East & Africa Probiotic Strains Market by Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.14. Rest of Middle East & Africa Probiotic Strains Market by Form, Value (US$ Bn), 2019 - 2032
      • 8.4.1.15. Rest of Middle East & Africa Probiotic Strains Market by End Use Application, Value (US$ Bn), 2019 - 2032
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. By End Use Application vs by Form Heat map
  • 9.2. Company Market Share Analysis, 2025
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Hansen Holding A/S
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Development
    • 9.4.2. Probi
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Product Portfolio
      • 9.4.2.3. Financial Overview
      • 9.4.2.4. Business Strategies and Development
    • 9.4.3. Aumgene Bioscience
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Product Portfolio
      • 9.4.3.3. Financial Overview
      • 9.4.3.4. Business Strategies and Development
    • 9.4.4. Virchow Biotech Private Limited
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Product Portfolio
      • 9.4.4.3. Financial Overview
      • 9.4.4.4. Business Strategies and Development
    • 9.4.5. Merck KGaA
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Product Portfolio
      • 9.4.5.3. Financial Overview
      • 9.4.5.4. Business Strategies and Development
    • 9.4.6. I. du Pont de Nemours and Company
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Product Portfolio
      • 9.4.6.3. Financial Overview
      • 9.4.6.4. Business Strategies and Development
    • 9.4.7. Koninklijke DSM N.V.
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Product Portfolio
      • 9.4.7.3. Financial Overview
      • 9.4.7.4. Business Strategies and Development
    • 9.4.8. Ganeden
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Product Portfolio
      • 9.4.8.3. Financial Overview
      • 9.4.8.4. Business Strategies and Development
    • 9.4.9. Lesaffre
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Product Portfolio
      • 9.4.9.3. Financial Overview
      • 9.4.9.4. Business Strategies and Development
    • 9.4.10. Essum AB
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Product Portfolio
      • 9.4.10.3. Financial Overview
      • 9.4.10.4. Business Strategies and Development
    • 9.4.11. Valio Dairy
      • 9.4.11.1. Company Overview
      • 9.4.11.2. Product Portfolio
      • 9.4.11.3. Financial Overview
      • 9.4.11.4. Business Strategies and Development
    • 9.4.12. BioGaia
      • 9.4.12.1. Company Overview
      • 9.4.12.2. Product Portfolio
      • 9.4.12.3. Financial Overview
      • 9.4.12.4. Business Strategies and Development
    • 9.4.13. Morinaga Milk Industry Co., Ltd
      • 9.4.13.1. Company Overview
      • 9.4.13.2. Product Portfolio
      • 9.4.13.3. Financial Overview
      • 9.4.13.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!